A pivotal phase 3 study of CITI-002
Latest Information Update: 22 Jun 2023
At a glance
- Drugs Halobetasol/Lidocaine (Primary)
- Indications Haemorrhoids
- Focus Registrational; Therapeutic Use
- Sponsors Citius Pharmaceuticals Inc
Most Recent Events
- 22 Jun 2023 New trial record